 | • レポートコード：MRC2302D013 • 出版社/出版日：Transparency Market Research / 2022年12月27日 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査レポートは、2022年に875億ドルであった世界の血液検査市場規模が2032年には2182億ドルとなり、予測期間の間に年平均9.6％増加すると展望しています。当レポートでは、血液検査の世界市場を調査対象とし、エグゼクティブサマリー、市場概要、市場の背景、血液検査の世界市場分析・予測、検査種類別（グルコース、A1C、ダイレクトLDL、脂質パネル、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競合分析、仮定、調査手法などの項目をまとめました。並びに、当レポートに記載されている企業情報には、Abbott、F. Hoffmann-La Roche AG、Bio-Rad Laboratories, Inc.、BioMerieux SA、Quest Diagnostics、Biomerica, Inc.、Becton, Dickinson and Company、Siemens Healthineers、Danaher Corporation、Trinity Biotech Plcなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場の背景 ・血液検査の世界市場分析・予測 ・世界の血液検査市場規模：検査種類別 - グルコース血液検査の市場規模 - A1C血液検査の市場規模 - ダイレクトLDL血液検査の市場規模 - 脂質パネル血液検査の市場規模 - その他血液検査の市場規模 ・世界の血液検査市場規模：地域別 - 北米の血液検査市場規模 - 中南米の血液検査市場規模 - ヨーロッパの血液検査市場規模 - アジア太平洋の血液検査市場規模 - 中東・アフリカの血液検査市場規模 ・市場構造分析 ・競合分析 ・仮定 ・調査手法 |
Blood Testing Market – Scope of Report
TMR’s report on the global blood testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global blood testing market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood testing market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the blood testing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood testing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global blood testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood testing market.
The report delves into the competitive landscape of the global blood testing market. Key players operating in the global blood testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global blood testing market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market blood testing.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Blood Testing Market Analysis 2015-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2015-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032
5.3.1. Glucose
5.3.2. A1C
5.3.3. Direct LDL
5.3.4. Lipid panel
5.3.5. Prostate-specific antigen
5.3.6. COVID-19
5.3.7. Bun testing
5.3.8. Vitamin D
5.3.9. Testosterone
5.3.10. ALT
5.3.11. Creatinine
5.3.12. Other Test Types
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2015-2021
5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032
6. Global Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Test Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Test Type
7.4. Key Takeaways
8. Latin America Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Test Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Test Type
8.4. Key Takeaways
9. Europe Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Test Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.4. Key Takeaways
10. Asia Pacific Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Test Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.4. Key Takeaways
11. Middle East and Africa Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Test Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.4. Key Takeaways
12. Key Countries Blood Testing Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2021
12.1.2.1. By Test Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2021
12.2.2.1. By Test Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2021
12.3.2.1. By Test Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2021
12.4.2.1. By Test Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2021
12.5.2.1. By Test Type
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2021
12.6.2.1. By Test Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2021
12.7.2.1. By Test Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2021
12.8.2.1. By Test Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2021
12.9.2.1. By Test Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2021
12.10.2.1. By Test Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2021
12.11.2.1. By Test Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2021
12.12.2.1. By Test Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2021
12.13.2.1. By Test Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2021
12.14.2.1. By Test Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2021
12.15.2.1. By Test Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2021
12.16.2.1. By Test Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2021
12.17.2.1. By Test Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2021
12.18.2.1. By Test Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2021
12.19.2.1. By Test Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Test Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Abbott
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. F. Hoffmann-La Roche AG
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Bio-Rad Laboratories, Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. BioMerieux SA
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Quest Diagnostics
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Biomerica, Inc.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Becton, Dickinson and Company
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Siemens Healthineers
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Danaher Corporation
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Trinity Biotech Plc
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology